Monitoring Agency Report for the quarter ended 30.06.2025
NOVAAGRI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
CARE Ratings, the appointed Monitoring Agency, has submitted its quarterly report on Nova Agritech's IPO proceeds utilisation for Q1FY26. The company raised Rs. 112 crore through a fresh public issue in January 2024, with net proceeds of Rs. 100.95 crore. As of 30 June 2025, Rs. 100.51 crore (nearly 99.6%) has been utilised across the stated objects — subsidiary investment for new formulation plant (Rs. 13.76 crore), expansion of existing formulation plant (Rs. 10.49 crore), company's working capital (Rs. 26.65 crore), subsidiary working capital (Rs. 43.36 crore), and general corporate purposes (Rs. 6.24 crore). Only Rs. 0.44 crore remains unutilised, parked in a fixed deposit for the new formulation plant project. The monitoring agency confirmed no deviation from the stated objects and no major variance from earlier reports. The company commenced commercial operations at its expanded formulation facility on 7 July 2025, funded by the IPO proceeds.
This is a positive update for shareholders — IPO funds have been deployed on schedule with no diversions or governance red flags. Achievement of commercial production at the expanded plant post-quarter-end signals that the growth investments are beginning to deliver operational results, though pending insecticide registrations remain a key watchpoint.